Prochlorperazine Edisylate Injection
Product Images NDC 23155-523

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Prochlorperazine Edisylate (NDC 23155-523). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

8115f153 5d56 47b3 B94f D2dd47c62d17 01

FDA Label Image

8115f153 5d56 47b3 B94f D2dd47c62d17 02

FDA Label Image

8115f153 5d56 47b3 B94f D2dd47c62d17 03

FDA Label Image

8115f153 5d56 47b3 B94f D2dd47c62d17 04

8115f153 5d56 47b3 B94f D2dd47c62d17 04
This is a product label for Prochlorperazine, a medication used for the treatment of nausea, vomiting, and vertigo. The medication is available in a 10mg/2mL strength and is intended for deep intramuscular or intravenous administration only. It is not meant for subcutaneous use. The product should be protected from light and must be kept covered. The label also includes the drug's National Drug Code (NDG) number and the manufacturer's name, which is Encaro Pharmaceutics.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.